Navigation Links
Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO
Date:11/21/2008

1 clinical trials and progressed further with the development of OXIGON(R), a small molecule intended for the treatment of AD and other disorders, including Parkinson's disease and other neurodegenerative diseases. Our development of OXIGON(R) was partially supported with federal funding from the National Institutes of Aging. We anticipate starting Phase 2 trials in AD patients next year.

3. Leverage our investment in our technology platforms:

  • We granted a non-exclusive, worldwide, royalty-bearing license to our ANTISENILIN(R) AD monoclonal antibody platform to Wyeth and Elan Pharmaceuticals. The license grants rights to Wyeth and Elan under Intellect's patents with respect to the development and sale of Bapineuzumab, a monoclonal antibody intended to treat AD. Wyeth and Elan are currently testing Bapineuzumab in several thousand Alzheimer's patients in a Phase 3 clinical trial. If successful, the drug could be launched early in 2012. Bapineuzumab has enormous sales potential as the first disease modifying drug in the field of AD and Intellect is entitled to a significant royalties on any future sales. The grant of this first license under our ANTISENILIN(R) patents was of great significance because it validated and established the value of our technology and of our business model that calls for broad licensing of our technology.

  • We recently granted an option to acquire a similar non-exclusive license to the ANTISENILIN(R) patents to another top tier pharmaceutical company that is developing its own monoclonal antibody for AD. The drug is currently being tested in humans. We are entitled to an upfront payment if and when this pharmaceutical company exercises the option in the first quarter of 2009 as well as patent milestones and royalties from sales. We are in discussions to grant additional licenses to oth
    '/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
4. Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc.
5. ActivBiotics Completes Sale of Fixed Assets; Expands Due Diligence Initiative for the Sale of Intellectual Property, Including Drug Product Candidates
6. Amarin Secures Global Intellectual Property Rights for Lipid Programs
7. ActivBiotics Intellectual Property Assets, Including Drug Product Candidates, Sold for $3.5 Million
8. Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School
9. Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimers Disease
10. Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
11. IC Sciences Announces Launch of ICS Advisory Services Intellectual Property Platforms Available Through ICSciences Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... The paradigm of ‘one drug, one ... can help predict the adverse and therapeutic effects of ... of Computational Biology at the Genomics Laboratory, Covance, will ... high-quality genomics when used as part of the QC ... data sets to identify key clinical targets even in ...
(Date:5/17/2013)... Darrington, WA (PRWEB) May 17, 2013 Tooth ... 5th graders showing active signs of the disease. The World ... children and nearly 100% of adults have cavities. What are ... Research is showing a strong connection between the oral ... why is this disease so rampant, yet it is also ...
(Date:5/16/2013)... In late 2012, Dr. Sarah Hart, of Palm ... China about Appearance Medicine . Although Dr. Hart regularly ... trip to lecture in China, and quite a different experience ... to 12 and 7 million people respectively. Interest in cosmetic ... point in time. As Dr. Hart passed through the Fuzhou ...
(Date:5/16/2013)... Ore. , May 16, 2013  HealthSparq, ... many of the nation,s largest regional health plans, ... America,s Health Insurance Plans (AHIP) Institute 2013 conference ... highlight survey results showing how health insurance companies ... for the consumer and marketplace demands for increased ...
Breaking Biology Technology:Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3
... Bolder BioTechnology, Inc. today announced that it has ... Innovation Research (SBIR) grant from the National Institute of ... of Health (NIH). The grant will be used ... the company,s proprietary long-acting growth hormone product, which is ...
... Offers Healthcare Workers Consistent Cleaning , ... IRVINE, Calif., Dec. 16 Advanced ... availability of the EVOTECH(TM) Endoscope Cleaner and Reprocessor, ... manual cleaning of endoscopes. The results of the ...
... Leadership, Vision and Experience to Company , ... Dec. 16 Xceleron, the global leader in predictive ... today Michael Butler, Ph.D., has been named President and ... Butler brings to Xceleron a balance of sales, operations ...
Cached Biology Technology:Bolder BioTechnology Receives $1.9 Million NIH Grant to Continue Development of Long-Acting Growth Hormone Product 2ASP Announces Availability of EVOTECH(TM) Endoscope Cleaner and Reprocessor - First Commercially Available System to Eliminate Manual Cleaning of Endoscopes 2Xceleron Names Michael Butler as President & CEO 2
(Date:5/16/2013)... creature with ,scissor hand-like, claws in fossil records and ... star. , The 505 million year old fossil ... is a distant ancestor of lobsters and scorpions, was ... role as Edward Scissorhands - a movie about an ... scissors for hands. , Kooteninchela deppi ...
(Date:5/16/2013)... can trigger hematopoiesis at sites outside the bone marrow ... of Ludwig-Maximilians-Universitaet (LMU) in Munich now show that a ... formation of blood cells. , Balanced hematopoiesis is essential ... development, hematopoiesis takes place mainly in the liver and ... bone marrow, and this tissue normally serves as the ...
(Date:5/16/2013)... Top neuroscientists from Canada and around the world ... Annual Canadian Neuroscience Meeting will showcase the latest ... system and reveal clues to understanding the disorders ... neuroscience research, and this meeting will showcase the ... the world," says Sam David, President of the ...
Breaking Biology News(10 mins):Actor Johnny Depp immortalized in ancient fossil find 2Herpes infections: Natural killer cells activate hematopoiesis 27th Annual Canadian Neuroscience Meeting, Toronto, May 20-24, 2013 2
... was responsible for about two-thirds of toxic lead that ... latter two-thirds of the 20th century, according to a ... . Researchers from Case Western Reserve University say ... cities across the U.S. and reinforces concerns about the ...
... blood sugar levels may also influence a person,s sensitivity to ... the University of Maryland School of Medicine. They found that ... as glucagon decreases the taste system,s sensitivity to sweetness. That ... how foods taste, according to the study published online June ...
... New York, NY, June 15 Robert H. Wurtz, ... is the recipient of the 2010 Neuroscience Prize of The ... brain processes visual information and controls eye movements laid the ... This research has led scientists to a deeper understanding of ...
Cached Biology News:Leaded gasoline predominant source of lead exposure in latter 20th century 2Leaded gasoline predominant source of lead exposure in latter 20th century 3UM School of Medicine scientists find hormone influences sensitivity to sweetness 2Neuroscientist Robert H. Wurtz receives the $500,000 Gruber neuroscience prize 2Neuroscientist Robert H. Wurtz receives the $500,000 Gruber neuroscience prize 3
Human peripheral blood eosinophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Monocyte-derived dendritic cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Dendritic Cells...
Umbilical cord blood CD14+ Monocytes, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Umbilical cord blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Biology Products: